Skip to main content
drug protocol number
GB002-3101
drug sponsor
Gossamer Bio
drug study
Seralutinib
drug trial site
King Faisal Specialist Hospital and Research Center (Riyadh), King Fahad Medical City (Riyadh)
drug status
Ongoing
drug phase